Featured News

    Shoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell Immunotherapies

    November 3, 2021
    Read More

    San Diego biotech raises $140M in quest for ‘one-size-fits-all’ cancer treatments

    November 3, 2021
    Read More

    Latest News

    BioWorld Insider Podcast: One-on-one with Medical Innovators

    December 10, 2021 |
    Read More

    Harnessing the body’s natural killers to target cancer

    December 5, 2021 |
    Read More

    Shoreline Biosciences To Present At Two Upcoming Investor Conferences

    November 23, 2021 |
    Read More

    Intelligent Cells: Shoreline Builds Immunotherapy Platform, Pipeline with $140M Financing

    November 8, 2021 |
    Read More

    California Life Sciences awarded Kite Pharma, a Gilead company, and Shoreline Biosciences the 2021 Strategic Partnership of the Year Award

    November 4, 2021 |
    Read More

    Developing Allogeneic Induced Pluripotent Stem Cell Based Therapies to Kill Cancer Cells with Kleanthis Xanthopoulos Shoreline Biosciences

    November 4, 2021 |
    Read More
    Load More